VEECOLLINS LIMITEDActive

Company number 10101631Private limited companyIncorporated 2016

Key figures

−£9,900-6,249.1%
Net assets 2025/26
-10 k-5 k05 k2020/212021/222022/232023/242024/252025/26

Like most small UK companies, VEECOLLINS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 k10 k15 k2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand10,16110,16110,16110,161—
Total assets10,16110,16110,16110,161100
Total liabilities10,00010,00010,00010,00010,000
Net assets / total equity161161161161-9,900
Average number of employees11100

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

The principal activity of the company during the period under review was the provision of healthcare services.

As described in the company's latest filed accounts.

Summary: VEECOLLINS LIMITED

Company

VEECOLLINS LIMITED is a private limited company registered with Companies House under company number 10101631. It was incorporated on 4 Apr 2016. Its status is active. The registered office is in London (SE16). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 30 Apr 2026); the company files dormant company accounts. Net assets were −£9,900, down 6,249.1% on the previous year. Total assets were £100 and total liabilities £10,000. The company had an average of 0 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Jan 2028. The next confirmation statement is due by 17 Apr 2027.